Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients

George SL, Bacon BR, Brunt EM, Mihindukulasuriya KL, Hoffmann J, Di Bisceglie AM. Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patients. Hepatology. 2009;49(3):729-738.

Publication Type:

Journal Article

Authors:

George, S.L.; Bacon, B.R.; Brunt, E.M.; Mihindukulasuriya, K.L.; Hoffmann, J.; A M Di Bisceglie

Source:

Hepatology, Volume 49, Issue 3, p.729-738 (2009)

Keywords:

Adult, Aged, Alanine, Alanine Transaminase, Antiviral Agents, Aspartate Aminotransferases, Biopsy, blood, Carcinoma, Disease, drug effects, drug therapy, Drug Therapy,Combination, Female, Fibrosis, Follow-Up Studies, genetics, Genotype, HCV, Hepacivirus, hepatitis, Hepatitis C, Humans, Inflammation, interferon, Interferon Alfa-2b, Interferon-alpha, Internal Medicine, Liver, Male, Medicine, Middle Aged, pathology, Patients, peginterferon, peginterferon alfa-2b, physiology, Polyethylene Glycols, Proteins, Recombinant Proteins, Research, Research Support, Ribavirin, Risk, Serum, sustained virologic response, SVR, therapeutic use, therapy, treatment, Treatment Outcome, virology

Notes:

PMC2731713

Cited On:

Monitoring Patients Who Are Starting HCV Treatment, Are on Treatment, or Have Completed Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/19072828

Export Citation:

RIS Format

Top